Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

ApoE genotype and abnormal auditory cortical potentials in healthy older females.

Irimajiri R, Golob EJ, Starr A.

Neurobiol Aging. 2010 Oct;31(10):1799-804. doi: 10.1016/j.neurobiolaging.2008.09.005. Epub 2008 Oct 30.

2.

Cortical event-related potentials in preclinical familial Alzheimer disease.

Golob EJ, Ringman JM, Irimajiri R, Bright S, Schaffer B, Medina LD, Starr A.

Neurology. 2009 Nov 17;73(20):1649-55. doi: 10.1212/WNL.0b013e3181c1de77.

3.

Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia.

Golob EJ, Irimajiri R, Starr A.

Brain. 2007 Mar;130(Pt 3):740-52. Epub 2007 Feb 9.

PMID:
17293359
4.

Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers.

Yu YW, Lin CH, Chen SP, Hong CJ, Tsai SJ.

Neurosci Lett. 2000 Nov 24;294(3):179-81.

PMID:
11072144
5.

Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.

Wang X, Wang J, He Y, Li H, Yuan H, Evans A, Yu X, He Y, Wang H.

J Alzheimers Dis. 2015;45(3):781-95. doi: 10.3233/JAD-142556.

PMID:
25624419
6.

Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status.

Monsell SE, Besser LM, Heller KB, Checkoway H, Litvan I, Kukull WA.

Parkinsonism Relat Disord. 2014 May;20(5):503-7. doi: 10.1016/j.parkreldis.2014.02.001. Epub 2014 Feb 13.

7.

Auditory event-related potentials during target detection are abnormal in mild cognitive impairment.

Golob EJ, Johnson JK, Starr A.

Clin Neurophysiol. 2002 Jan;113(1):151-61.

8.

Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.

Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.

J Clin Psychiatry. 2012 Dec;73(12):1555-62. doi: 10.4088/JCP.12m07702. Epub 2012 Oct 30.

PMID:
23146133
9.

Increased N200 and P300 latencies in cognitively impaired elderly carrying ApoE ε-4 allele.

Cintra MTG, Ávila RT, Soares TO, Cunha LCM, Silveira KD, de Moraes EN, Simas KR, Fernandes RB, Gonçalves DU, de Rezende NA, Bicalho MAC.

Int J Geriatr Psychiatry. 2018 Feb;33(2):e221-e227. doi: 10.1002/gps.4773. Epub 2017 Aug 22.

PMID:
28833437
10.

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease.

Waring JF, Tang Q, Robieson WZ, King DP, Das U, Dubow J, Dutta S, Marek GJ, Gault LM.

J Alzheimers Dis. 2015;47(1):137-48. doi: 10.3233/JAD-142589.

11.

Saccade latency delays in young apolipoprotein E (APOE) epsilon 4 carriers.

Niechwiej-Szwedo E, Tapper A, Gonzalez D, Bradley RM, Duncan R.

Behav Brain Res. 2018 Nov 1;353:91-97. doi: 10.1016/j.bbr.2018.07.002. Epub 2018 Jul 9.

PMID:
30003976
12.

Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.

Bracco L, Piccini C, Baccini M, Bessi V, Biancucci F, Nacmias B, Bagnoli S, Sorbi S.

Dement Geriatr Cogn Disord. 2007;24(6):483-91. Epub 2007 Nov 15.

PMID:
18025782
13.

Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.

Lasser RA, Dukoff R, Levy J, Levin R, Lehtimäki T, Seubert P, Sunderland T.

Int J Geriatr Psychiatry. 1998 Nov;13(11):767-74.

PMID:
9850873
14.

[Patterns of cognitive impairment and apolipoprotein genotype in persons with Alzheimer's disease].

Łuczywek E, Pffefer A, Nowicka A, Czyzewski K, ŁaŁowski M, Styczyńska M, Barcikowska M.

Neurol Neurochir Pol. 2001 Nov-Dec;35(6):1021-33. Polish.

PMID:
11987699
15.

The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease.

Sabbagh MN, Malek-Ahmadi M, Dugger BN, Lee K, Sue LI, Serrano G, Walker DG, Davis K, Jacobson SA, Beach TG.

BMC Neurol. 2013 May 11;13:44. doi: 10.1186/1471-2377-13-44.

16.

Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.

Langbaum JB, Chen K, Caselli RJ, Lee W, Reschke C, Bandy D, Alexander GE, Burns CM, Kaszniak AW, Reeder SA, Corneveaux JJ, Allen AN, Pruzin J, Huentelman MJ, Fleisher AS, Reiman EM.

Arch Neurol. 2010 Apr;67(4):462-8. doi: 10.1001/archneurol.2010.30.

17.

Family history of Alzheimer's disease and hippocampal structure in healthy people.

Donix M, Burggren AC, Suthana NA, Siddarth P, Ekstrom AD, Krupa AK, Jones M, Martin-Harris L, Ercoli LM, Miller KJ, Small GW, Bookheimer SY.

Am J Psychiatry. 2010 Nov;167(11):1399-406. doi: 10.1176/appi.ajp.2010.09111575. Epub 2010 Aug 4.

18.

Apolipoprotein E genotype and memory in the sixth decade of life.

Schultz MR, Lyons MJ, Franz CE, Grant MD, Boake C, Jacobson KC, Xian H, Schellenberg GD, Eisen SA, Kremen WS.

Neurology. 2008 May 6;70(19 Pt 2):1771-7. doi: 10.1212/01.wnl.0000286941.74372.cc. Epub 2008 Jan 30.

19.

Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.

Yoo HB, Lee HW, Shin S, Park SW, Choi JS, Jung HY, Cha J, Lee JM, Lee JY.

Curr Alzheimer Res. 2014 Feb;11(2):137-44.

PMID:
24479631
20.

Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.

Ewers M, Zhong Z, Bürger K, Wallin A, Blennow K, Teipel SJ, Shen Y, Hampel H.

Brain. 2008 May;131(Pt 5):1252-8. doi: 10.1093/brain/awn034. Epub 2008 Mar 11.

PMID:
18334538

Supplemental Content

Support Center